NCT01781741View on ClinicalTrials.gov

Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Stage III-IV Non-small Cell Lung Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 6, 2013

Primary Completion Date

November 30, 2015

Study Completion Date

October 14, 2020

Conditions
Recurrent Non-small Cell Lung CancerStage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Interventions
COMBINATION_PRODUCT

therapeutic lymphadenectomy (TEMLA) and Stereotactic Body radiation therapy (SBRT)

Undergo TEMLA and SBRT

OTHER

quality-of-life assessment

Ancillary studies

Trial Locations (1)

14263

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT01781741 - Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Stage III-IV Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter